Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADI-PEG 20 in ASS1-negative Malignant Pleural Mesothelioma
NCT01279967Phase 2Unknown
- Sponsor
- Barts Health NHS Trust
- Start
- Jan 2011
- Primary completion
- Jan 2015
- Countries
- 1
01
Overview
A Phase 2 trial of Pegargiminase in malignant pleural mesothelioma (MPM), sponsored by Barts Health NHS Trust. Status: unknown.
02
Drugs
Pegargiminase
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT01279967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01279967.